High-flow nasal oxygen a safe, efficient treatment for COVID-19 patients not in an ICU

Autor: David Marquette, Stéphane Jouneau, Christine Lineau, Mathieu Lederlin, Marie Langelot, Jean Louis Bizec, Françoise Martin, Charles Ricordel, Tiphaine Guy, Audrey Créac'hcadec, Baptiste Arnouat, A. Salé

Publikováno v: European Respiratory Journal
European Respiratory Journal, 2020, 56 (5), pp.2001154. ⟨10.1183/13993003.01154-2020⟩
European Respiratory Journal, European Respiratory Society, 2020, 56 (5), pp.2001154. ⟨10.1183/13993003.01154-2020⟩
The European Respiratory Journal
article-version (AM) Accepted Manuscript

The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease (COVID-19), now recognised by the WHO as a pandemic, emerged in late 2019 in China [1]. Patients infected with SARS-CoV-2 can develop severe pneumoni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8920246f056904ba77b51a282edfdbb7
https://hal.science/hal-02929630